Freenome Email Format
Biotechnology ResearchCalifornia, United States201-500 Employees
Freenome is a Brisbane, California-based biotechnology research company founded in 2014. It develops blood-based tests intended to identify cancer at its earliest, most treatable stages by integrating data from multiple biological layers with advanced analytics. The company's initial focus is a screening test aimed at detecting early-stage colorectal cancer and related precancerous lesions known as advanced adenomas. Freenome operates in the biotechnology research sector, seeking to provide tools that enable prevention, early detection, and treatment decisions. In November 2025, the company announced the appointment of Rob Guigley as chief commercial officer, a leadership update reflecting ongoing organizational development.